Sunday, September 30, 2018

New cancer vaccine shows early promise for patients with HER2-positive cancers

Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial.

from Top Health News -- ScienceDaily https://ift.tt/2RfNc8m
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover what triggers belly fat as we age

Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery re...